Product image of Kalium-Natriumklorid Sad (Potassium Chloride, Sodium Chloride) supplied by GNH India

Kalium-Natriumklorid Sad

Active Ingredient:
Potassium Chloride, Sodium Chloride
Origin:
EU

Kalium-Natriumklorid Sad (Potassium Chloride, Sodium Chloride)

Potassium chloride and sodium chloride, the active ingredient in Kalium-Natriumklorid Sad, is an electrolyte solution presented as an injection solution for intravenous use. It treats electrolyte deficiencies such as hypokalemia and hyponatremia in patients requiring rapid correction.

GNH India supplies Kalium-Natriumklorid Sad as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Amgros I/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kalium-Natriumklorid Sad is an electrolyte solution used to correct specific electrolyte disturbances.

  • Hypokalemia: restores potassium levels in patients with low serum potassium.
  • Hyponatremia: raises sodium concentration in patients with low serum sodium.
  • Electrolyte imbalance: normalizes overall electrolyte balance during acute care.

How It Works

  • The injection delivers potassium and sodium ions directly into the bloodstream, increasing extracellular concentrations of these electrolytes. This restores normal cellular membrane potential, supports nerve and muscle function, and helps re‑establish fluid and acid‑base balance. The rapid intravenous route allows prompt correction of deficits in patients unable to tolerate oral supplementation.

Side Effects

Kalium-Natriumklorid Sad may be associated with several adverse reactions.

Common Side Effects

  • Injection site pain: mild discomfort at the infusion site.
  • Nausea: transient feeling of queasiness.
  • Transient hyperkalemia: temporary rise in serum potassium.
  • Transient hypernatremia: temporary rise in serum sodium.
  • Headache: mild to moderate head discomfort.
  • Dizziness: brief episodes of light‑headedness.

Serious or Rare Side Effects

  • Severe hyperkalemia: dangerous elevation of potassium that can affect cardiac rhythm.
  • Severe hypernatremia: marked sodium increase leading to neurologic symptoms.
  • Cardiac arrhythmia: irregular heartbeats triggered by electrolyte shifts.
  • Anaphylactic reaction: rare severe allergic response.
  • Vein thrombosis: clot formation at the infusion site.
  • Tissue necrosis: local tissue death if extravasation occurs.

Precautions & Warnings

When using Kalium-Natriumklorid Sad, clinicians should observe several safety measures.

  • Monitor serum electrolytes: check potassium and sodium levels before and during therapy.
  • Adjust dose in renal impairment: reduce infusion rate in patients with reduced kidney function.
  • Use cautiously in cardiac disease: avoid rapid shifts that may provoke arrhythmias.
  • Contraindicated in hyperkalemia or hypernatremia: do not administer when serum levels are already elevated.
  • Compatibility: do not mix with calcium‑containing solutions.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Kalium-Natriumklorid Sad can interact with several medications; awareness of these interactions helps prevent complications.

Major Interactions (Avoid)

  • ACE inhibitors: may increase potassium levels and risk hyperkalemia.
  • Potassium‑sparing diuretics: combined use can cause dangerous hyperkalemia.
  • NSAIDs: may reduce renal clearance of potassium, raising serum levels.
  • Digitalis glycosides: heightened risk of arrhythmia when potassium rises.

Moderate Interactions (Monitor Closely)

  • Loop diuretics: may require higher potassium supplementation.
  • Insulin therapy: can cause rapid intracellular shift of potassium.
  • Beta‑adrenergic agonists: may lower serum potassium, necessitating monitoring.

Frequently Asked Questions

Kalium-Natriumklorid Sad is an injectable electrolyte solution used to rapidly correct low potassium (hypokalemia), low sodium (hyponatremia), and general electrolyte imbalances in patients who need intravenous therapy.

The formulation provides potassium and sodium ions directly into the bloodstream, raising extracellular concentrations. This restores normal cellular membrane potential, supports nerve and muscle activity, and helps re‑balance fluid and acid‑base status.

The prescribed dose is determined by the treating clinician based on the patient’s serum electrolyte levels, clinical condition, and renal function. The healthcare professional sets the infusion rate and total amount required.

Safety data for use in pregnancy or lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.

Kalium-Natriumklorid Sad combines both potassium and sodium chloride in a single IV formulation, offering the convenience of correcting two major electrolyte deficits simultaneously. Alternative products may contain only one electrolyte or different concentrations, requiring separate administrations.

The product must be stored at 2‑8 °C, kept refrigerated, protected from light, and should never be frozen or shaken. Before use, inspect the vial for particulate matter and ensure the solution is at room temperature if required for infusion.

Kalium-Natriumklorid Sad is given intravenously. The healthcare professional selects an appropriate infusion set, dilutes the solution if needed, and administers it at a rate guided by the patient’s electrolyte levels and clinical status.

Serious risks include severe hyperkalemia or hypernatremia, which can cause cardiac arrhythmias, and rare allergic reactions such as anaphylaxis. Monitoring serum electrolytes and cardiac status during infusion helps mitigate these risks.

Patients with existing hyperkalemia, hypernatremia, or severe renal impairment that cannot be safely managed should not receive this product. It is also contraindicated in individuals with known hypersensitivity to potassium chloride, sodium chloride, or any excipients in the formulation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Potassium Chloride, Sodium Chloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT